CLRO — Effective Time for Reverse Stock Split
Jun 2, 2025, 9:00:00 PM UTC
Summary
ClearOne, Inc. will effect a 1-for-15 reverse stock split of its issued and outstanding common stock at 5:00 PM ET on June 2, 2025, following stockholder approval at a special meeting on May 30, 2025. This reverse stock split aims to increase the company's per share market price to comply with NASDAQ's minimum bid price requirement, thereby facilitating continued listing. Post-split, the company's shares will begin trading on a reverse-split-adjusted basis on NASDAQ under the symbol 'CLRO', reducing issued shares from approximately 26 million to about 1.7 million. Fractional shares will not be issued, and the par value will remain at $0.001.
Company
CLEARONE INC (CLRO)NASDAQ — Technology: Manufacturing, Communication Equipment: Telephone & Telegraph Apparatus
www.clearone.comSimilar Events
Effective Time for Reverse Stock Split
Pixelworks, Inc. will implement a 1-for-12 reverse stock split of its common stock effective June 6, 2025, at 4:01 p.m. Eastern Time, following approval at its Annual Meeting on May 23. The split, which will consolidate twelve shares into one, is aimed at adjusting the company's stock price and enhancing its market appeal. The adjustment will not affect the total market value of shares owned by shareholders, but will adjust the number of outstanding shares and the exercise price of equity awards. All shareholders will have their positions automatically adjusted without any action required on their part, and from June 9, the stock will trade under the existing symbol PXLW on a split-adjusted basis.
Corporate ActionEffective Time for Reverse Stock Split
Applied DNA Sciences, Inc. will implement a reverse stock split effective at 12:01 a.m. Eastern Time on June 2, 2025, with a ratio of one-for-fifteen. As a result, approximately 7.8 million outstanding shares will be consolidated into about 0.5 million shares. Fractional shares will not be issued; any fractional amounts will be rounded up to the nearest whole share. This adjustment affects the shares' exercise prices and available shares under the incentive stock plans. The stock will continue trading on the Nasdaq Capital Market under the ticker symbol "APDN" without any changes.
stock splitEffective Time for Reverse Stock Split - 5:00 PM ET
Lyell Immunopharma, Inc. will implement a reverse stock split of its common stock at a 1-for-20 ratio, effective at 5:00 PM ET on May 30, 2025. This decision follows the stockholder approval during the 2025 Annual Meeting held on May 15, 2025. After the split, the number of outstanding shares will decrease from approximately 296.2 million to about 14.8 million shares. The reverse stock split aims to increase the stock price by reducing the number of shares in circulation. The adjusted shares will begin trading on Nasdaq on June 2, 2025, under a new CUSIP number, 55083R203. Proportional adjustments will also be made to stock options and restricted stock units, ensuring no shareholder's percentage ownership is altered by the action.
Corporate ActionEffective Date of Reverse Stock Split
Cero Therapeutics Holdings, Inc. will implement a one-for-twenty (1:20) reverse stock split effective June 10, 2025 at 12:01 a.m. ET. The company’s Board of Directors approved the split immediately following the Annual Meeting of Stockholders on May 29, 2025, where stockholders also approved an increase of 2 million shares in the company’s 2024 Equity Incentive Plan. This strategic move aims to fulfill regulatory requirements and adapt to market conditions, with the expectation that post-split trading will commence soon after the effective date.
Reverse Stock Split Effective Date